Key Highlights of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market 2025-2034: Growth Dynamics, Trends, and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Forecasted Expansion Rate of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Over the 2025–2034 Period?
In recent times, the market size for the contract development and manufacturing organization (CDMO) of advanced therapy medicinal products has experienced a swift expansion. Forecasts indicate a rise from $5.31 billion in 2024 to $6.22 billion in 2025, marking a compound annual growth rate (CAGR) of 17.0%. Several factors contributed to this growth during the historical phase. These include an escalating number of ATMP clinical trials, heightened awareness and conviction among the research community about the advantages of advanced therapy, the existence of numerous ATMP CDMOs, growing endeavors in the advancement of novel therapies for diverse diseases, and supportive governmental initiatives.
The market size for contract development and manufacturing organizations (CDMO) engaged in advanced therapy medicinal products is projected to experience significant expansion in the coming years. By 2029, it’s predicted to reach a value of $11.53 billion, translating to a compound annual growth rate (CAGR) of 16.7%. This development is spurred by high capital investments from CDMOs, the proliferation of novices in the cell and gene therapy (CGT) sector, escalated funding and investment towards cell and gene therapy development, incrementing pharmaceutical R&D expenditure, and a rising number of clinical trials for ATMPs. Notable trends for the projected period cover progress in AAV biomanufacturing tools, cell and gene therapy manufacturing growth, technological breakthroughs in cell and gene therapy, mounting requirement for advanced technology access, and the blending of forefront technologies like CRISPR and next-generation sequencing for superior precision.
What Strategic Factors Are Influencing the Accelerated Growth of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
The growth of the advanced therapy medicinal products CDMO market is anticipated to be driven by the escalating numbers of clinical trials. These trials, which assess the safety and effectiveness of medical initiatives ranging from drugs to preventive measures, are increasing to accommodate the rising demand for revolutionary treatments and manage the expanding global disease burden. As advanced therapy medicinal products are employed, there is an increased need for CDMO manufacturing services which utilize specialized skills and facilities. The data from clinical trials are crucial for enhancing manufacturing, guaranteeing scalability, and maintaining quality to satisfy larger clinical and commercial demands. As per the Association of the British Pharmaceutical Industry, a trade association based in the UK, there was a slight increase of 4.3% in the total count of industry clinical trials initiated annually in the UK, from 394 in 2021 to 411 in 2022. Consequently, the expansion of the advanced therapy medicinal products CDMO market is being propelled by the growing number of clinical trials.
Request Your Free Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=15719&type=smp
Who Are the Leading Organizations Fueling the Expansion of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Resonac Corporation
• Lonza Group AG
• Catalent Inc.
Which Cutting-Edge Trends Are Expected to Drive the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market’s Growth?
Major corporations in the advanced therapy medicinal products CDMO industry are innovating cell therapy manufacturing services to mitigate challenges in the production of cell therapies and expedite their partners’ development ventures. These are contractual development and manufacturing services that range from initial pre-clinical stages to late-phase clinical trials and product commercialization. For example, in January 2024, Israel-based Pluristem Therapeutics Inc. that turns cells into solutions debuted its PluriCDMO, a fresh business division that focuses on cell therapy manufacturing. It employs a proprietary bioreactor technology which enables 3D cell reproduction, paving the way for production of various cell types like stem cells, induced pluripotent stem cells, exosomes, and immune therapies. PluriCDMO aims to supply essential, high-caliber medicines to patients while ensuring consistency from one batch to another, in a scalable, cost-effective manner that adheres to good manufacturing practices.
Pre-order Your Report for Quick and Easy Delivery!
What Are the Main Segments of the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market, and How Are They Evolving?
The advanced therapy medicinal products contract development and manufacturing organization (CDMO) market covered in this report is segmented –
1) By Product: Gene Therapy, Cell Therapy, Tissue Engineered
2) By Phase: Phase I, Phase II, Phase III, Phase IV
3) By Indication: Oncology, Cardiology, Central Nervous System And Musculoskeletal, Infectious Disease, Dermatology, Endocrine, Metabolic, Genetic, Immunology And Inflammation, Ophthalmology, Hematology
Subsegments:
1) By Gene Therapy: Viral Vectors, Non-Viral Vectors, Dna Or Rna-Based Products
2) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy
3) By Tissue Engineered: Skin Substitutes, Cartilage And Bone Tissue, Vascular Grafts And Organs
Which Regions Are Most Influential in Expanding the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market?
North America was the largest region in the advanced therapy medicinal product contract development and manufacturing organization (CDMO) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the advanced therapy medicinal products contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
How Is the Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization (CDMO) Market Categorized and Defined in the Industry?
An advanced therapy medicinal product contract development and manufacturing organization (CDMO) is a specialized service provider that assists in the development and manufacturing of advanced therapy medicinal products. The objective of an advanced therapy medicinal product CDMO is to provide the expertise, infrastructure, and resources required for advanced therapy medicinal product development and manufacturing.
Browse Through More Similar Reports By The Business Research Company:
Advanced Lead Acid Battery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/advanced-lead-acid-battery-global-market-report
Advanced Glass Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/advanced-glass-global-market-report
Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
